Midwest Institute for Clinical Research

Midwest Institute for Clinical Research

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Midwest Institute for Clinical Research (MICR) is a well-established, private contract research organization (CRO) with over 35 years of experience in the Indianapolis area. It operates as a service provider, conducting Phase I-IV clinical trials on behalf of pharmaceutical and medical device sponsors, having executed over 550 protocols. The company's business model centers on recruiting volunteer participants for paid clinical trials, providing a critical link between sponsors, patients, and regulatory outcomes. Its reputation is built on a commitment to quality, detail, and personalized care for trial volunteers.

Clinical ResearchDrug Delivery

Technology Platform

Integrated clinical trial operational infrastructure and volunteer recruitment ecosystem, including clinical facilities, patient screening systems, data management, and regulatory compliance expertise focused on efficient trial execution.

Opportunities

The growing trend of pharmaceutical outsourcing to CROs and the persistent industry challenge of patient recruitment present significant opportunities.
MICR's strong local community presence and focus on volunteer care position it well to capitalize on the demand for efficient, high-quality trial sites, especially for decentralized trial elements and diverse patient enrollment.

Risk Factors

Key risks include dependence on sponsor contracts, intense competition from larger CROs, operational risks related to patient recruitment delays or safety issues, and regulatory changes that could increase compliance costs.
Geographic concentration in a single city also limits scalability and increases exposure to local market fluctuations.

Competitive Landscape

MICR competes in the fragmented clinical research site and mid-sized CRO market. Competitors range from large global CROs (IQVIA, Parexel, PPD) to other regional, site-focused research organizations and academic medical centers. Its differentiation lies in its long-standing local reputation, personalized volunteer care, and focused operational quality in the Indianapolis region.